Angelika Schäfer

1.3k citations
13 papers · 903 indexed · h-index 10
Topics
Phytochemicals and Antioxidant Activities (2 papers)Peptidase Inhibition and Analysis (2 papers)Protease and Inhibitor Mechanisms (2 papers)
Partner nations
Germany

In The Last Decade

Angelika Schäfer

13 papers receiving 862 citations

Peers

Angelika Schäfer
Comparison fields: 5 of 109
  • Immunology 325
  • Molecular Biology 220
  • Biochemistry 135
  • Endocrinology, Diabetes and Metabolism 110
  • Plant Science 78
Replace Seon‐Young Han with:
Seon‐Young Han South Korea
Luca Barella Switzerland
Jihong Yang China
Keiko Morikawa Japan
Jason M. Hoffman United States
Lotte F. Hansen United States
Seong-Gene Lee South Korea
Sandrine Dubrac Austria
Gi Soo Youn South Korea
Angelika Schäfer relative to Seon‐Young Han South Korea Seon‐Young Han's profile →
Citations per field
00.5×3.0×
Seon‐Young Han · 1×
Citations per year

Countries citing papers authored by Angelika Schäfer

Since Specialization
Citations

This map shows the geographic impact of Angelika Schäfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelika Schäfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelika Schäfer more than expected).

Fields of papers citing papers by Angelika Schäfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelika Schäfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelika Schäfer. The network helps show where Angelika Schäfer may publish in the future.

Co-authorship network of co-authors of Angelika Schäfer

This figure shows the co-authorship network connecting the top 25 collaborators of Angelika Schäfer. A scholar is included among the top collaborators of Angelika Schäfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelika Schäfer. Angelika Schäfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 6
2 27
3 21
4 119
5 13
6 86
7 164
8 12
9 359
10 14
11 7
12 67
13 8

About Angelika Schäfer

Angelika Schäfer is a scholar working on Biochemistry, Pharmacy and Molecular Medicine, having authored 13 papers that have together received 903 indexed citations. Recurring topics across this work include Phytochemicals and Antioxidant Activities (2 papers), Peptidase Inhibition and Analysis (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Biochemistry (135 citations), Immunology (325 citations) and Immunology and Allergy (61 citations). Angelika Schäfer has collaborated with scholars based in Germany. Frequent co-authors include Petra Högger, Tanja Grimm, Kurt S. Zänker, Peter Friedl, Stefan Borgmann, Stephan Grabbe, Matthias Gunzer, Eckhart Kämpgen, Eva‐Bettina Bröcker and Dieter Marmé. Their work appears in journals such as Nucleic Acids Research, Immunity and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026